文献速递精神分裂症与精神病性障碍物质与行为成瘾

两个首发精神病队列中当前使用大麻的甲基化特征

Methylomic signature of current cannabis use in two first-episode psychosis cohorts.
PubMed 文献 · Mol Psychiatry · 2024-10-16

本研究在两个独立的首发精神病(FEP)队列中,比较当前使用大麻者与从未使用者的血液DNA甲基化谱,合并样本682人(当前使用者188人,从未使用者494人)。跨队列荟萃分析发现CAVIN1基因的cg11669285位点甲基化与当前大麻使用相关,且独立于烟草相关表观遗传特征;高效力大麻(THC>10%)分析中MCU基因的cg11669285位点达阵列-wide显著。包含大麻使用与FEP状态交互项的模型发现两个位点与当前大麻使用显著相关,交互项名义显著,提示FEP状态可能调节大麻使用对DNA甲基化的影响。

要点

  • 当前大麻使用与CAVIN1基因cg11669285位点差异甲基化相关,独立于烟草表观遗传特征。
  • 高效力大麻(THC>10%)使用与MCU基因cg11669285位点甲基化达阵列-wide显著。
  • 大麻相关表观遗传变异邻近免疫与线粒体功能基因;FEP状态可能调节大麻对甲基化的影响(交互项名义显著)。

核心结论

  • 当前大麻使用与血液DNA甲基化改变相关,涉及CAVIN1和MCU基因位点及免疫、线粒体功能相关通路。
  • FEP状态可能调节大麻使用对DNA甲基化的影响,交互项名义显著。

研究设计与样本

  • 研究纳入两个独立的首发精神病(FEP)队列,合并样本682人,其中当前大麻使用者188人、从未使用者494人。
  • 使用Illumina DNA甲基化阵列平台对外周血DNA样本进行甲基化谱检测,并开展跨队列荟萃分析。

主要发现

  • 跨队列荟萃分析发现CAVIN1基因的cg11669285位点甲基化与当前大麻使用差异相关,超过阵列-wide显著性阈值,且独立于烟草相关表观遗传特征。
  • 在高效力(THC>10%)当前大麻使用分析中,MCU基因的cg11669285位点达到阵列-wide显著。
  • 通路与区域分析识别出大麻相关表观遗传变异邻近免疫和线粒体功能相关基因。
  • 包含大麻使用与FEP状态交互项的模型识别出两个位点与当前大麻使用显著相关,交互项名义显著,提示FEP状态可能调节大麻使用对DNA甲基化的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The rising prevalence and legalisation of cannabis worldwide have underscored the need for a comprehensive understanding of its biological impact, particularly on mental health. Epigenetic mechanisms, specifically DNA methylation, have gained increasing recognition as vital factors in the interplay between risk factors and mental health. This study aimed to explore the effects of current cannabis use and high-potency cannabis on DNA methylation in two independent cohorts of individuals experiencing first-episode psychosis (FEP) compared to control subjects. The combined sample consisted of 682 participants (188 current cannabis users and 494 never users). DNA methylation profiles were generated on blood-derived DNA samples using the Illumina DNA methylation array platform. A meta-analysis across cohorts identified one CpG site (cg11669285) in the CAVIN1 gene that showed differential methylation with current cannabis use, surpassing the array-wide significance threshold, and independent of the tobacco-related epigenetic signature. Furthermore, a CpG site localised in the MCU gene (cg11669285) achieved array-wide significance in an analysis of the effect of high-potency (THC = > 10%) current cannabis use. Pathway and regional analyses identified cannabis-related epigenetic variation proximal to genes linked to immune and mitochondrial function, both of which are known to be influenced by cannabinoids. Interestingly, a model including an interaction term between cannabis use and FEP status identified two sites that were significantly associated with current cannabis use with a nominally significant interaction suggesting that FEP status might moderate how cannabis use affects DNA methylation. Overall, these findings contribute to our understanding of the epigenetic impact of current cannabis use and highlight potential molecular pathways affected by cannabis exposure.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Dempster EL, Wong CCY, Burrage J, et al. Methylomic signature of current cannabis use in two first-episode psychosis cohorts. Mol Psychiatry. 2024. PMID: 39406996. doi:10.1038/s41380-024-02689-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。